510(k) Report

510(k) · Cleared

Cleared

Anti-Mutated Citrullinated Vimentin Eia

K092399510(k) TraditionalCleared Jul 1, 2010329-day reviewClass II21 CFR 866.5775

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Orgentec Diagnostika GmbH · OQZ Anti-Mutated Citrullinated Vimentin Igg

Cleared on Jul 1, 2010 as substantially equivalent to K052133 (Eurodiagnostica, 2005) after a 329-day review. Its family tree reaches back 1 generation to 2005.

Decided
Jul 1, 2010
Review
329 days
Class
Class II
Product code
OQZ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K052133 (2005). No later device cites it as a predicate yet.

K052133 · Immunoscan RA Anti-CCP Test System · Eurodiagnostica · 20052006200820102012
K052133 · Immunoscan RA Anti-CCP Test System · Eurodiagnostica · 20050
  1. Root · 1 generation backK052133 Immunoscan RA Anti-CCP Test SystemEurodiagnostica · 2005
  2. This deviceK092399 Anti-Mutated Citrullinated Vimentin EiaOrgentec Diagnostika GmbH · 2010
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K052133Immunoscan RA Anti-CCP Test SystemEurodiagnostica2005—
0 (this device)K092399Anti-Mutated Citrullinated Vimentin EiaOrgentec Diagnostika GmbH2010—
FIG. 1 — Lineage of K092399, 2005–2010Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OQZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K052133Immunoscan RA Anti-CCP Test SystemEurodiagnostica2005—

Also cleared against K052133: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 3 other devices also cite its predicate K052133.

How does its category compare?

All OQZ devices

OQZ Anti-Mutated Citrullinated Vimentin Igg: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · OQZ

1in 2010

2010: 1
2007high 1 (2010) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OQZ

Too few OQZ 510(k)s in any year since 2007 to give a median.

Recalls per year · OQZ

No recall names OQZ since 2007.

Adverse event reports per year · OQZ

No MAUDE report names OQZ since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20101—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

Anti-MCV®D is an indirect solid phase enzyme immunoassay (ELISA) for the qualitative and semi-quantitative measurement of IgO crass auto antibodies against mutated citrullinated vimentin (MCV) in human serum. The assay is intended for in vitro diagnostic use only as an aid in the diagnosis of Rheumatoid Arthritis in conjunction with other laboratory and clinical findings.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K092399: Anti-Mutated Citrullinated Vimentin Eia.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K092399

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026